PROF Stock Summary and Trading Ideas (Profound Medical Corp. | NASDAQ:PROF)

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

What symbol and exchange does Profound Medical Corp. shares trade?

Profound Medical Corp. trades on the NASDAQ stock market under the symbol PROF.

What is Profound Medical Corp. stock price doing today?

As of October 9, 2026, PROF stock price declined to $6.90 with 391,056 million shares trading.

What is Profound Medical Corp.'s Beta?

PROF has a beta of 1.19, meaning it tends to be more sensitive to market movements. PROF has a correlation of 0.05 to the broad based SPY ETF.

How much is Profound Medical Corp. worth?

PROF has a market cap of $252.07 million. This is considered a Small Cap stock.

How much money does Profound Medical Corp. make?

Last quarter Profound Medical Corp. reported $2 million in Revenue and -$.26 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.02.

What is the highest and lowest price Profound Medical Corp. traded in the last 3 year period?

In the last 3 years, PROF traded as high as $11.69 and as low as $3.76.

What are the top ETFs holding Profound Medical Corp.?

The top ETF exchange traded funds that PROF belongs to (by Net Assets): QQQS, DFIC.

Is Profound Medical Corp. (PROF) a good investment?

PROF has underperformed the market in the last year with a return of +4.1%, while the SPY ETF gained +17.1%. In the last 3 month period, PROF fell short of the market, returning -5.9%, while SPY returned +3.8%. However, in the most recent 2 weeks PROF has outperformed the stock market by returning +19.8%, while SPY returned +0.9%.

What are the support and resistance levels for Profound Medical Corp. (PROF)?

PROF support price is $6.57 and resistance is $7.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PROF shares will trade within this expected range on the day.